Clinical Trials Sponsored by Usona Institute

Total 74901 results

Usona Institute

Terminated

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

Major Depressive Disorder

United States
Usona Institute

Completed

Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers

Pharmacokinetics | Tolerability | Safety

United States
Usona Institute

Completed

An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics

Pharmacokinetics | QTc Interval

United States
Yale University
Usona Institute

Not yet recruiting

Open-Label Psilocybin

Safety, Feasibility, and Tolerability of Psilocybin Treatment in Individuals With Functional Impairment Due to Psychiatric Symptoms
University of Chicago
Usona Institute

Recruiting

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Major Depressive Disorder | Borderline Personality Disorder

United States
Usona Institute
Worldwide Clinical Trials

Recruiting

Psilocybin for Major Depressive Disorder (MDD) (uAspire)

Depressive Disorder, Major

United States
University of Utah
Usona Institute

Completed

Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer (HOPE)

Cancer

United States
University of Colorado, Denver
Usona Institute

Not yet recruiting

A Phase 1b Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Breast Cancer | Ovarian Cancer

United States
Usona Institute
The Emmes Company, LLC

Completed

A Study of Psilocybin for Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States
University of Utah
Heffter Research Institute; Usona Institute

Recruiting

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout (PAPR)

Depression | Burnout, Professional

United States
USANA Health Sciences

Recruiting

A Clinical Study to Determine if Beta Glucan Reduces the Incidence, Duration or Severity of URTIs Among Skiers

Upper Respiratory Tract Infections | Mental Stress

United States
USANA Health Sciences

Not yet recruiting

Safety and Tolerability of 2 Dietary Supplement Beverages Designed to Maintain Healthy Blood Pressure.

Tolerance | Safety Issues

United States
Brain and Cognition Discovery Foundation
Usona Institute; Braxia Scientific Corp.

Completed

Psilocybin for Treatment-Resistant Depression

Treatment Resistant Depression

Canada
USANA Health Sciences

Completed

Effect of a Multivitamin/Multimineral/Phytochemical Dietary Supplement on Indices of Human Health

Healthy

United States
University of Wisconsin, Madison
Usona Institute; Tiny Blue Dot Foundation

Enrolling by invitation

Consciousness, Psilocybin, and Well-Being (CoPE Pilot)

Healthy | Sleep | Psychedelic Experiences

United States
Sona Nanotech Inc

Terminated

Performance Study of SONA Saliva C-19 Rapid Test

Covid19 | Corona Virus Infection | Sars-CoV-2 Infection

Canada
University of Memphis
USANA Health Sciences

Recruiting

Impact of Jump Start Nutrition Program on Weight Loss and Associated Measures

Weight Loss

United States
USANA Health Sciences
U.S. Ski & Snowboard

Completed

The Acute Effects of a Dietary Supplement on Cognitive Performance in Highly Trained Athletes.

Reaction Time

United States
USANA Health Sciences
KGK Science Inc.

Completed

Effect of a MVM Dietary Supplement on Indices of Human Health

Metabolic Syndrome

Canada
University of Memphis
USANA Health Sciences

Completed

Active Nutrition Program on Weight Loss

Weight Loss

United States
Utah State University
USANA Health Sciences

Completed

Effects of Dietary Supplements on Response to Air Pollution

Inflammation
Joshua Woolley
Heffter Research Institute; Usona Institute; River Styx Foundation; Stupski Foundation

Completed

Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors

Depression | Distress | Grief

United States
Intermountain Health Care, Inc.
USANA Health Sciences

Completed

Vitamin D Supplementation in Knee Osteoarthritis (VitD-OA)

Osteoarthritis, Knee | Vitamin D Supplementation
Sona PASHAEI

Recruiting

The Effect of Ginger and Peppermint on Postoperative Nausea and Vomiting in Patients After Thyroid Surgery

Postoperative Nausea and Vomiting

Turkey
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
USANA Health Sciences
Roseman University of Health Sciences

Completed

The Effects of an Oral Probiotic Intervention With or Without a Novel ADP-1 Toothpaste

Oral Health

United States
USANA Health Sciences
Elegant And Olive Health Clinic, Canada

Completed

A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition

Protective Qi Insufficiency (a Condition Term From TCM)

Canada
Central Institute of Mental Health, Mannheim
Charite University, Berlin, Germany; German Federal Ministry of Education and... and other collaborators

Active, not recruiting

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression (EPIsoDE)

Treatment-resistant Depression

Germany
USANA Health Sciences
Elegant And Olive Health Clinic, Canada

Completed

An Evaluation of Proglucamune in the Treatment of Protective Qi Insufficiency

Protective Qi Insufficiency

Canada
Yvan Beaussant, MD, MSci
Heffter Research Institute; Usona Institute; Oppenheimer Family Psychosocial... and other collaborators

Active, not recruiting

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care (PATH)

Terminal Illness | Psychotherapy | Psilocybin | Hospice | Demoralization | Cancer-related Problem/Condition | Terminal Cancer | Cancer Terminal

United States
Karolinska Institutet
The Swedish Institute

Recruiting

MIDWIZE - Strengthening Midwives

Midwifery

Uganda
Karolinska Institutet
Children's National Research Institute

Completed

Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients

Exercise | Myositis

Sweden
Institut Curie
National Cancer Institute, France

Completed

ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery (ER-One)

Breast Surgery

France
Institut Bergonié
National Cancer Institute, France

Completed

A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (RADIOSARP)

Soft-tissue Sarcoma

France
Institut Curie

Completed

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Breast Cancer

France
Institut Curie

Completed

Bone Marrow and Blood Samples From Patients With Metastatic Choroid Melanoma

Intraocular Melanoma
Institut Curie
National Cancer Institute, France

Recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV) (LOC-R01)

Lymphoma, Large B-Cell, Diffuse | Central Nervous System Neoplasms, Primary

France
Institut Bergonié
National Cancer Institute, France

Completed

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial (FRAIL-06)

Lymphoma

France
Institut Bergonié
National Cancer Institute, France

Completed

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer (HORGEN)

Breast Cancer

France
Institut Curie

Unknown

Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye

Intraocular Melanoma

France
Institute of Rheumatology, Prague
Karolinska Institutet

Completed

Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With PM and DM (Prometheus)

Dermatomyositis | Polymyositis

Czech Republic
Jules Bordet Institute
AstraZeneca; Institut Curie

Active, not recruiting

Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer: (Neo-CheckRay)

Luminal B

France, Belgium
The Netherlands Cancer Institute
Institut Curie

Terminated

Pre- Versus Postoperative Accelerated Partial Breast Irradiation (PAPBI-2)

Breast Cancer | Neoplasms, Breast | Cancer of the Breast

France, Netherlands, Portugal, Spain
Institut Bergonié
National Cancer Institute, France

Completed

Validation of a Screening Tool in Geriatric Oncology (ONCODAGE)

Lymphoma | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Lung Cancer | Prostate Cancer

France
Institut Bergonié

Completed

Effect of Advertisements on Treatment Compliance in Women With Breast Cancer

Breast Cancer
Institut Curie

Completed

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

France
Institut Bergonié

Completed

MRI in Evaluating Early Response to Chemotherapy in Women Receiving Chemotherapy for Infiltrating Breast Cancer

Breast Cancer

France
Institut Bergonié

Completed

Psychological and Social Factors That May Increase the Risk of Developing Chronic Pain After Surgery in Women With Breast Cancer

Pain | Breast Cancer | Psychosocial Effects of Cancer and Its Treatment
Institut Curie

Unknown

Study of Tumor and Blood Samples From Women With Breast Cancer

Breast Cancer

France
Institut Bergonié

Unknown

Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

France

Clinical Trials Sponsored by Usona Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations